The document discusses delirium, including its definition, subtypes, risk factors, pathophysiology, management, and prevention. It defines delirium as a disturbance in consciousness and cognition caused by a medical condition or substance. The two main subtypes are hyperactive and hypoactive delirium. Risk factors include older age, dementia, medical illness, surgery, medications, sleep deprivation, and inflammation. The pathophysiology involves an imbalance between cholinergic and dopaminergic neurotransmitters. Management focuses on treating the underlying cause, avoiding medications that can worsen delirium, and addressing non-pharmacological factors. Prevention emphasizes good patient care, such as avoiding dehydration, hypoxia, and unnecessary medications.
Drugs used in the management of Dementia.pdfEugenMweemba
This document discusses drugs used to manage different types of dementia, including Alzheimer's disease, vascular dementia, and dementia with Lewy bodies. It provides information on signs and symptoms, risk factors, clinical course, pathophysiology, and treatment guidelines for each type. For Alzheimer's disease, the recommended first-line treatments are acetylcholinesterase inhibitors or memantine. For vascular dementia, treatment focuses on managing risk factors to prevent additional strokes. Dementia with Lewy bodies may be treated with acetylcholinesterase inhibitors or memantine, though antipsychotics must be used carefully due to risk of worsening symptoms.
Metabolic disoders internal medicine and neuroscienceNeilVincentDeAsis
This document discusses acquired metabolic disorders of the nervous system that result from failure of other organ systems. It focuses on hypoxic-ischemic encephalopathy, where lack of oxygen and blood flow to the brain causes global disturbance of cerebral function. The main causes are discussed as well as the clinical features and progression from confusion to stupor and coma. Laboratory tests that can help identify potential causes are also outlined.
Chronic alcoholism can lead to serious psychological, social, and medical consequences. Psychologically, heavy drinking can damage brain centers and cause issues with perception, coordination, and higher mental processes. Socially, excessive alcohol is linked to problems like violence and family abandonment. Medically, long-term alcohol abuse raises the risks of conditions like Wernicke's encephalopathy, Korsakoff's syndrome, brain atrophy, and gastrointestinal issues like ulcers and cancer. Neuroimaging can reveal brain damage and atrophy from chronic alcoholism.
This document discusses delirium, listing its key features as a disturbance in attention, awareness, cognition, and perception that develops over hours to days and fluctuates in severity. It notes delirium is caused by medical conditions, substance use, or medications and presents as inattention, disorganized thinking, and altered consciousness. Risk factors include age over 75, dementia, multiple comorbidities and medications. Precipitants include infections, metabolic disturbances, drugs, and surgery. Evaluation involves assessing attention, thinking, and level of consciousness using tools like CAM. Treatment focuses on resolving underlying causes while preventing complications like pneumonia.
- Neurocognitive disorders include delirium, disorders due to Lewy bodies, Alzheimer's disease, frontotemporal disorders, vascular disorders, and traumatic brain injuries.
- Delirium involves an acute change in consciousness and cognition that fluctuates in severity. It is often caused by medical issues, medications, or substance withdrawal. Treatment focuses on resolving the underlying cause.
- Disorders like those due to Lewy bodies, Alzheimer's disease, and frontotemporal disorders cause progressive cognitive decline due to brain changes. Symptoms and severity vary by type. Management includes medications, environmental modifications, and supportive care.
- Vascular and traumatic brain injury disorders arise from disruptions to the brain's
This document provides an overview of delirium, including its definition, history, characteristics, epidemiology, risk factors, causes, pathophysiology, clinical features, diagnosis, differential diagnosis, course and prognosis, and treatment. Some key points covered include:
- Delirium is defined as an acute impairment of attention, consciousness, and cognition that fluctuates in severity.
- Risk factors include older age, medical illnesses, cognitive impairment, and polypharmacy.
- Causes include infections, withdrawal, toxins/drugs, hypoxia, and metabolic disturbances.
- The pathophysiology is not fully understood but may involve neurotransmitter imbalances and blood-brain barrier disruption.
- Diagnosis involves
Delirium is characterized by disturbances in attention, awareness, cognition and perception that develop over a short period of time and tend to fluctuate. It is commonly caused by medical illnesses, medications, substance withdrawal or intoxication in older patients. Key features include inattention, disorganized thinking and altered consciousness. It is diagnosed using tools like the Confusion Assessment Method. Treatment focuses on identifying and addressing the underlying medical causes, ensuring patient safety, and preventing complications like pneumonia or falls.
1. Several treatable causes of dementia are discussed including normal pressure hydrocephalus, brain tumors, infections like HIV-associated neurocognitive disorders and neurosyphilis, head injuries that cause chronic traumatic encephalopathy, and progressive multifocal leukoencephalopathy.
2. Normal pressure hydrocephalus presents with a triad of gait impairment, urinary incontinence, and dementia. It is treated with shunt surgery which improves symptoms in about 70% of patients.
3. Brain tumors, infections, head injuries, and other medical conditions can cause dementia through various mechanisms including compression, edema, disruption of blood flow, and diffuse effects on brain tissue. Recognizing and treating the
Drugs used in the management of Dementia.pdfEugenMweemba
This document discusses drugs used to manage different types of dementia, including Alzheimer's disease, vascular dementia, and dementia with Lewy bodies. It provides information on signs and symptoms, risk factors, clinical course, pathophysiology, and treatment guidelines for each type. For Alzheimer's disease, the recommended first-line treatments are acetylcholinesterase inhibitors or memantine. For vascular dementia, treatment focuses on managing risk factors to prevent additional strokes. Dementia with Lewy bodies may be treated with acetylcholinesterase inhibitors or memantine, though antipsychotics must be used carefully due to risk of worsening symptoms.
Metabolic disoders internal medicine and neuroscienceNeilVincentDeAsis
This document discusses acquired metabolic disorders of the nervous system that result from failure of other organ systems. It focuses on hypoxic-ischemic encephalopathy, where lack of oxygen and blood flow to the brain causes global disturbance of cerebral function. The main causes are discussed as well as the clinical features and progression from confusion to stupor and coma. Laboratory tests that can help identify potential causes are also outlined.
Chronic alcoholism can lead to serious psychological, social, and medical consequences. Psychologically, heavy drinking can damage brain centers and cause issues with perception, coordination, and higher mental processes. Socially, excessive alcohol is linked to problems like violence and family abandonment. Medically, long-term alcohol abuse raises the risks of conditions like Wernicke's encephalopathy, Korsakoff's syndrome, brain atrophy, and gastrointestinal issues like ulcers and cancer. Neuroimaging can reveal brain damage and atrophy from chronic alcoholism.
This document discusses delirium, listing its key features as a disturbance in attention, awareness, cognition, and perception that develops over hours to days and fluctuates in severity. It notes delirium is caused by medical conditions, substance use, or medications and presents as inattention, disorganized thinking, and altered consciousness. Risk factors include age over 75, dementia, multiple comorbidities and medications. Precipitants include infections, metabolic disturbances, drugs, and surgery. Evaluation involves assessing attention, thinking, and level of consciousness using tools like CAM. Treatment focuses on resolving underlying causes while preventing complications like pneumonia.
- Neurocognitive disorders include delirium, disorders due to Lewy bodies, Alzheimer's disease, frontotemporal disorders, vascular disorders, and traumatic brain injuries.
- Delirium involves an acute change in consciousness and cognition that fluctuates in severity. It is often caused by medical issues, medications, or substance withdrawal. Treatment focuses on resolving the underlying cause.
- Disorders like those due to Lewy bodies, Alzheimer's disease, and frontotemporal disorders cause progressive cognitive decline due to brain changes. Symptoms and severity vary by type. Management includes medications, environmental modifications, and supportive care.
- Vascular and traumatic brain injury disorders arise from disruptions to the brain's
This document provides an overview of delirium, including its definition, history, characteristics, epidemiology, risk factors, causes, pathophysiology, clinical features, diagnosis, differential diagnosis, course and prognosis, and treatment. Some key points covered include:
- Delirium is defined as an acute impairment of attention, consciousness, and cognition that fluctuates in severity.
- Risk factors include older age, medical illnesses, cognitive impairment, and polypharmacy.
- Causes include infections, withdrawal, toxins/drugs, hypoxia, and metabolic disturbances.
- The pathophysiology is not fully understood but may involve neurotransmitter imbalances and blood-brain barrier disruption.
- Diagnosis involves
Delirium is characterized by disturbances in attention, awareness, cognition and perception that develop over a short period of time and tend to fluctuate. It is commonly caused by medical illnesses, medications, substance withdrawal or intoxication in older patients. Key features include inattention, disorganized thinking and altered consciousness. It is diagnosed using tools like the Confusion Assessment Method. Treatment focuses on identifying and addressing the underlying medical causes, ensuring patient safety, and preventing complications like pneumonia or falls.
1. Several treatable causes of dementia are discussed including normal pressure hydrocephalus, brain tumors, infections like HIV-associated neurocognitive disorders and neurosyphilis, head injuries that cause chronic traumatic encephalopathy, and progressive multifocal leukoencephalopathy.
2. Normal pressure hydrocephalus presents with a triad of gait impairment, urinary incontinence, and dementia. It is treated with shunt surgery which improves symptoms in about 70% of patients.
3. Brain tumors, infections, head injuries, and other medical conditions can cause dementia through various mechanisms including compression, edema, disruption of blood flow, and diffuse effects on brain tissue. Recognizing and treating the
This document discusses hypoxic-ischemic encephalopathy (HIE) and the potential use of therapeutic hypothermia as a treatment. It provides definitions of HIE, describes the pathology and causes. It outlines the evolving nature of brain injury after an hypoxic event and discusses potential mechanisms of hypothermia including modulation of excitotoxicity, free radicals, and apoptosis. It summarizes studies in animal models showing hypothermia initiated within 6 hours and continued for 2-3 days can reduce brain injury. The document concludes that while preliminary human trials are promising, more research is still needed to establish safety and efficacy of hypothermia as a treatment for HIE.
Alzheimer's disease is a progressive brain disorder that destroys memory and thinking skills. It results from abnormal buildup of proteins in the brain that cause nerve cell death. Risk increases with age and family history. Symptoms start with mild memory loss and worsen over time, eventually causing severe brain damage. The only way to definitively diagnose is through brain autopsy. Currently, there is no cure and treatment focuses on managing symptoms and slowing progression.
This document discusses delirium, dementia, and headaches. It provides detailed information on the definition, causes, symptoms, diagnosis and treatment of delirium. It describes some of the main causes of dementia like Alzheimer's disease and Normal Pressure Hydrocephalus. It also discusses different headache syndromes like migraines, tension headaches, and cluster headaches. It highlights some important life-threatening causes of headaches such as brain tumors and subarachnoid hemorrhage.
1. Schizophrenia is a chronic neuropsychiatric disorder affecting about 1% of the world's population that imposes a large economic burden.
2. While the exact causes remain unclear, current research suggests schizophrenia involves alterations in brain development and circuits during early development. Genetics also play a role as risk factors.
3. Recent advances in treatment include new atypical antipsychotic medications that target both dopamine and serotonin receptors, as well as research into alternative treatments targeting negative symptoms, cognitive impairments, and underlying neuropathology and metabolic abnormalities.
Dementia is characterized by progressive loss of intellectual function, especially memory loss. Cortical dementia affects areas like the temporal cortex and causes major changes in memory and language, while subcortical dementia affects areas like the thalamus and causes behavioral changes and motor slowing. Common causes of dementia include Alzheimer's disease, Lewy body disease, vascular dementia, and frontotemporal dementias. Tests can help determine if dementia has an underlying neurodegenerative, structural, infectious, or metabolic cause. Treatment depends on the specific cause but may include cholinesterase inhibitors or management of behavioral symptoms.
This document provides an overview of coma, including its definition, causes, signs and symptoms, diagnosis, treatment, and management. Coma is defined as a state of deep unconsciousness where the brain's alerting and arousal functions are affected. Causes can include metabolic abnormalities, infections, structural brain injuries, seizures, or lack of oxygen/glucose to the brain. Diagnosis involves assessing responsiveness using the Glasgow Coma Scale, examining pupils, ordering imaging tests, and determining the underlying cause. Treatment focuses on stabilizing the patient, treating any reversible causes, providing supportive care, and preventing increased intracranial pressure.
The document summarizes several key physiological changes that occur in the central nervous system with aging. It discusses changes in brain morphology like brain atrophy and widening of sulci. There are reductions in neurons, myelinated axons and neurotransmitter function. Cerebral blood flow decreases along with metabolic demand. Calcium regulation is also impaired with aging impacting neurotransmitter release. The hypothalamic-pituitary-adrenal axis shows changes reducing stress response capacity. Overall the aging brain shows structural, metabolic and functional declines impacting cognition, mood and homeostasis.
The document discusses several neurocognitive disorders including delirium, neurocognitive disorder due to Lewy bodies, neurocognitive disorder due to Alzheimer's disease, frontotemporal neurocognitive disorder, vascular neurocognitive disorder, and neurocognitive disorder due to traumatic brain injury. It provides details on the causes, symptoms, risk factors, and treatment options for each disorder. The disorders are characterized by impairments in cognitive functioning and mental abilities caused by underlying conditions that damage brain cells or their connections.
This document discusses renal and hepatic encephalopathy. It defines uremic encephalopathy as a brain disorder that occurs in patients with untreated or inadequately treated kidney disease. Symptoms range from mild to severe and fluctuate depending on kidney function. Uremic toxins that accumulate due to renal dysfunction are a primary cause. Treatment involves optimizing dialysis to adequately remove toxins. Other types of encephalopathy discussed include dialysis dementia, central pontine myelinolysis, seizures, and restless leg syndrome. Causes, clinical features, diagnosis and management are described for each condition.
The document discusses seizures, including their pathophysiology, classification, and common causes. It provides details on status epilepticus, focal vs. generalized seizures, and reactive seizures caused by metabolic derangements, infectious diseases, drugs/toxins, trauma, and other medical conditions. The key information is that seizures can be primary/epileptic or secondary/reactive, have different classifications including partial and generalized, and common causes include electrolyte imbalances, infections, drugs/alcohol, and trauma.
This document discusses reversible causes of dementia and delirium. It begins by defining major neurocognitive disorder and reversible dementias. Common reversible causes of dementia include central nervous system infections, normal pressure hydrocephalus, nutritional deficiencies, drugs, endocrine disorders, depression, and sleep apnea. Delirium is then discussed, including risk factors, pathophysiology, clinical subtypes, DSM-5 criteria, assessment scales, differential diagnosis, course, prevention, and management. Reversible dementias are estimated to account for 8-40% of dementia cases. Early diagnosis and treatment of the underlying cause can improve cognitive functioning.
Neurocognitive disorders includes : Delirium and Dementia.
This presentation focuses on causes, risk factors, management and how to prevent its complication
NEUROLOGICAL MANIFESTION OF RENAL DISEASENeurologyKota
This document summarizes various neurological complications that can occur in patients with renal disease. It discusses central nervous system complications such as encephalopathy, dementia, and cerebrovascular disease. It describes the pathophysiology and treatment of various types of encephalopathy including uremic encephalopathy, Wernicke's encephalopathy, and dialysis encephalopathy. It also discusses peripheral nervous system complications including mononeuropathy, polyneuropathy, and myopathy.
This document discusses consciousness and disorders of consciousness. It begins by explaining that normal consciousness depends on interaction between the cerebral hemispheres and rostral reticular activating system in the brainstem. Disorders that disrupt these areas can cause altered consciousness states like unconsciousness, confusion, delirium, and coma. Coma is defined as an unarousable, unresponsive state. The causes, assessments, and management of disorders of consciousness like coma are then outlined.
This document summarizes delirium, including its definition, epidemiology, types, and various hypotheses about its neurobiology and etiology. Delirium is an acute fluctuating neurobehavioral syndrome caused by neuronal disruption from systemic disturbances. It commonly occurs in 1-2% of elderly individuals and up to 87% of ICU patients requiring mechanical ventilation. The document discusses several hypotheses for the neurobiological mechanisms of delirium, including neurotransmitter imbalance, inflammation, neuronal aging, oxidative stress, circadian rhythm disruption, and network disconnectivity. It also reviews predisposing and precipitating risk factors. The hypotheses are meant to be complementary rather than competing explanations for delirium's pathophysiology.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
This document discusses hypoxic-ischemic encephalopathy (HIE) and the potential use of therapeutic hypothermia as a treatment. It provides definitions of HIE, describes the pathology and causes. It outlines the evolving nature of brain injury after an hypoxic event and discusses potential mechanisms of hypothermia including modulation of excitotoxicity, free radicals, and apoptosis. It summarizes studies in animal models showing hypothermia initiated within 6 hours and continued for 2-3 days can reduce brain injury. The document concludes that while preliminary human trials are promising, more research is still needed to establish safety and efficacy of hypothermia as a treatment for HIE.
Alzheimer's disease is a progressive brain disorder that destroys memory and thinking skills. It results from abnormal buildup of proteins in the brain that cause nerve cell death. Risk increases with age and family history. Symptoms start with mild memory loss and worsen over time, eventually causing severe brain damage. The only way to definitively diagnose is through brain autopsy. Currently, there is no cure and treatment focuses on managing symptoms and slowing progression.
This document discusses delirium, dementia, and headaches. It provides detailed information on the definition, causes, symptoms, diagnosis and treatment of delirium. It describes some of the main causes of dementia like Alzheimer's disease and Normal Pressure Hydrocephalus. It also discusses different headache syndromes like migraines, tension headaches, and cluster headaches. It highlights some important life-threatening causes of headaches such as brain tumors and subarachnoid hemorrhage.
1. Schizophrenia is a chronic neuropsychiatric disorder affecting about 1% of the world's population that imposes a large economic burden.
2. While the exact causes remain unclear, current research suggests schizophrenia involves alterations in brain development and circuits during early development. Genetics also play a role as risk factors.
3. Recent advances in treatment include new atypical antipsychotic medications that target both dopamine and serotonin receptors, as well as research into alternative treatments targeting negative symptoms, cognitive impairments, and underlying neuropathology and metabolic abnormalities.
Dementia is characterized by progressive loss of intellectual function, especially memory loss. Cortical dementia affects areas like the temporal cortex and causes major changes in memory and language, while subcortical dementia affects areas like the thalamus and causes behavioral changes and motor slowing. Common causes of dementia include Alzheimer's disease, Lewy body disease, vascular dementia, and frontotemporal dementias. Tests can help determine if dementia has an underlying neurodegenerative, structural, infectious, or metabolic cause. Treatment depends on the specific cause but may include cholinesterase inhibitors or management of behavioral symptoms.
This document provides an overview of coma, including its definition, causes, signs and symptoms, diagnosis, treatment, and management. Coma is defined as a state of deep unconsciousness where the brain's alerting and arousal functions are affected. Causes can include metabolic abnormalities, infections, structural brain injuries, seizures, or lack of oxygen/glucose to the brain. Diagnosis involves assessing responsiveness using the Glasgow Coma Scale, examining pupils, ordering imaging tests, and determining the underlying cause. Treatment focuses on stabilizing the patient, treating any reversible causes, providing supportive care, and preventing increased intracranial pressure.
The document summarizes several key physiological changes that occur in the central nervous system with aging. It discusses changes in brain morphology like brain atrophy and widening of sulci. There are reductions in neurons, myelinated axons and neurotransmitter function. Cerebral blood flow decreases along with metabolic demand. Calcium regulation is also impaired with aging impacting neurotransmitter release. The hypothalamic-pituitary-adrenal axis shows changes reducing stress response capacity. Overall the aging brain shows structural, metabolic and functional declines impacting cognition, mood and homeostasis.
The document discusses several neurocognitive disorders including delirium, neurocognitive disorder due to Lewy bodies, neurocognitive disorder due to Alzheimer's disease, frontotemporal neurocognitive disorder, vascular neurocognitive disorder, and neurocognitive disorder due to traumatic brain injury. It provides details on the causes, symptoms, risk factors, and treatment options for each disorder. The disorders are characterized by impairments in cognitive functioning and mental abilities caused by underlying conditions that damage brain cells or their connections.
This document discusses renal and hepatic encephalopathy. It defines uremic encephalopathy as a brain disorder that occurs in patients with untreated or inadequately treated kidney disease. Symptoms range from mild to severe and fluctuate depending on kidney function. Uremic toxins that accumulate due to renal dysfunction are a primary cause. Treatment involves optimizing dialysis to adequately remove toxins. Other types of encephalopathy discussed include dialysis dementia, central pontine myelinolysis, seizures, and restless leg syndrome. Causes, clinical features, diagnosis and management are described for each condition.
The document discusses seizures, including their pathophysiology, classification, and common causes. It provides details on status epilepticus, focal vs. generalized seizures, and reactive seizures caused by metabolic derangements, infectious diseases, drugs/toxins, trauma, and other medical conditions. The key information is that seizures can be primary/epileptic or secondary/reactive, have different classifications including partial and generalized, and common causes include electrolyte imbalances, infections, drugs/alcohol, and trauma.
This document discusses reversible causes of dementia and delirium. It begins by defining major neurocognitive disorder and reversible dementias. Common reversible causes of dementia include central nervous system infections, normal pressure hydrocephalus, nutritional deficiencies, drugs, endocrine disorders, depression, and sleep apnea. Delirium is then discussed, including risk factors, pathophysiology, clinical subtypes, DSM-5 criteria, assessment scales, differential diagnosis, course, prevention, and management. Reversible dementias are estimated to account for 8-40% of dementia cases. Early diagnosis and treatment of the underlying cause can improve cognitive functioning.
Neurocognitive disorders includes : Delirium and Dementia.
This presentation focuses on causes, risk factors, management and how to prevent its complication
NEUROLOGICAL MANIFESTION OF RENAL DISEASENeurologyKota
This document summarizes various neurological complications that can occur in patients with renal disease. It discusses central nervous system complications such as encephalopathy, dementia, and cerebrovascular disease. It describes the pathophysiology and treatment of various types of encephalopathy including uremic encephalopathy, Wernicke's encephalopathy, and dialysis encephalopathy. It also discusses peripheral nervous system complications including mononeuropathy, polyneuropathy, and myopathy.
This document discusses consciousness and disorders of consciousness. It begins by explaining that normal consciousness depends on interaction between the cerebral hemispheres and rostral reticular activating system in the brainstem. Disorders that disrupt these areas can cause altered consciousness states like unconsciousness, confusion, delirium, and coma. Coma is defined as an unarousable, unresponsive state. The causes, assessments, and management of disorders of consciousness like coma are then outlined.
This document summarizes delirium, including its definition, epidemiology, types, and various hypotheses about its neurobiology and etiology. Delirium is an acute fluctuating neurobehavioral syndrome caused by neuronal disruption from systemic disturbances. It commonly occurs in 1-2% of elderly individuals and up to 87% of ICU patients requiring mechanical ventilation. The document discusses several hypotheses for the neurobiological mechanisms of delirium, including neurotransmitter imbalance, inflammation, neuronal aging, oxidative stress, circadian rhythm disruption, and network disconnectivity. It also reviews predisposing and precipitating risk factors. The hypotheses are meant to be complementary rather than competing explanations for delirium's pathophysiology.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Pathophys of Delirium.ppt.pdf
1. What is delirium?
Why is it important?
Clinical Spectrum
General Risk Factors
Pathoetiological Model
Management
References
1
2. What is delirium?
Why is it important?
Clinical Spectrum
General Risk Factors
Pathoetiological Model
Management
References
2
3. I will not be discussing Delirium Tremens as the pathophysiology of
this form of delirium while not distinct, is somewhat different.
3
4. 4
Delirium is a neurobehavioral syndrome caused by the transient disruption of
normal neuronal activity secondary to systemic disturbances.
A delirious integrates external information incorrectly, which produces behavioral
responses that are inadequate to the environment.
5. DEFINITION:
A. Disturbance of consciousness with reduced ability to focus, sustain or shift
attention.
B. A change in cognition or a perceptual disturbance that is not better counted
for by dementia.
C. e disturbance develops acutely and fluctuates during the course of the day.
D. e disturbance is a the direct physiological consequence of a general medical
condition, medication, or other drug.
CAM is a standardized screening tool for patient with suspected delirium
It is 95% sensitive and specific, is easily googled and is essentially the DSM definition turned
into an algorithm
5
6. 6
Delirium often initiates a cascade of events culminating in loss of independence,
increased morbidity and mortality, and increased health care costs.
Delirium occurs up to 56% of hospitalized patients, up to 80% of mechanically
ventilated ICU patients and up to 70% of non-ventilated ICU patients
ICU delirium predicts a 3- to 11-fold increased risk of death at 6 months even after
controlling for relevant covariates such as severity of illness.
increased hospital cost of $2,500 per patient directly attributable to delirium. is
adds up $6.9 billion each year.
7. Subtypes noted as far back as the Greeks, and largely hold to this day.
hyperactive type was characterized by cognitive and behavioral disturbances
as well as sleep disruption and was termed “Phrenitis” It was marked by
excited, restless behavior and increased level of arousal.
Hypoactive type was termed ‘Lethargus’, and was characterized by
sleepiness, listlessness, memory loss, and inertia. Decreased psychomotor
activity is a predominant symptom and patients appear somnolent.
7
8. 8
Dementia and old age are the leading risk factors for delirium
Dementia:
• At least two thirds of cases of delirium occur in patients with underlying dementia
or cognitive impairment,
• Both delirium and dementia have been shown to be associated with decreased
cerebral oxidative metabolism, cholinergic deficiency, and inflammation.
Age:
It is useful to Apply the concept of "homeostenosis" (the age-associated decline in
physiologic reserve in body systems) when considering how age-related changes in
the brain predispose older persons to delirium during physiologic disturbances that
are tolerated in younger individuals.
Changes in the brain with normal aging include:
• a 28% decline in brain blood flow,
• neuron loss in many regions as high as 35%
• Decreasing concentrations norepinephrine, acetylcholine, dopamine, and GABA
e role of these changes as well as the other risk factors listed will be elaborated
shortly…
9. is is a basic model of delirium, and I stress the word basic.
While I don’t want to go through each piece of this model
individually, I intend to make the main components of it clear.
Understanding the pathophysiology of delirium is essential to the
management because of the numerous possible etiologies.
9
10. In case you couldn’t find it in this simple schematic, I’ve
highlighted the endpoint of interest, delirium
10
11. e current consensus is that
overactivity of the dopaminergic system
underactivity of the cholinergic system
are the key factors in delirium.
11
14. e major pathogenic mechanism in delirium is thus often presumed to be central cholinergic
deficiency.
e cholinergic system is widely involved in arousal, attention, memory, and rapid-eye-
movement (REM) sleep.
Acetylcholine plays an important role in consciousness, perhaps by modulating the signal-noise
ratio of sensory and cognitive input and focusing awareness
A deficiency of cholinergic function relative to that of other neurotransmitters can be expected to
alter the efficiency of these mental mechanisms
Low levels of acetylcholine (ACh) in plasma and cerebrospinal fluid (CSF) have been described
in delirious patients.
is belief stems from a well-described association between delirium and anticholinergic toxins
such as Angel's Trumpet Jimson weed and medications such as atropine.
e administration of anticholinergic substances results in the characteristic manifestations of
delirium including typical electroencephalogram (EEG) changes.
Age-related overall reductions in acetylcholine release and muscarinic receptor function which
predisposes elderly persons to harmful effects of cholinergic inhibition.
And because of the decreased cerebral perfusion, even mild hypoxia in the elderly inhibits ACh
synthesis and release.
14
15. Higher levels for serum anticholinergic activity (SAA) have been associated with an
increased likelihood of delirium
resolving delirium is correlated with decreasing SAA suggesting A dose-response
relationship between symptoms of delirium and SAA
A high SAA (i.e., >20) has a predictive value for delirium defined as confusion
assessment method positive of 100%.
15
16. Many reasons the elderly are susceptible to cholinergic decline is because of
problems surrounding cerebral profusion and hypoxia
16
17. I don’t think I need to list the numerous factors in the critically ill and
postoperative patients that can lead to decreased oxygen exchange,
increased O2 demand, and decreased cerebral perfusion
With aging comes a broad decline in cardiovascular and respiratory
reserves. Studies suggest that by age 85, vital capacity is reduced by nearly
40% and the arterio-alveolar gradient widens.
delirious patients experienced a 42% reduction in overall cerebral blood
flow (CBF).
Cerebral hypoxia ➙ oxidative metabolism failure ➙ ATP-ase pump system
failure ➙ ionic gradients cannot be maintained ➙ neuronal membrane
instability and possible cell death, Na+ & Ca++ influx, K+ efflux.
It is theorized that the excess inward flux of Ca++ that precipitates the most
significant neurobehavioral disturbances observed in delirious patients.
Cholinergic neurotransmission is particularly sensitive to metabolic insults,
because ACh synthesis requires acetyl CoA, a key intermediate linking the
glycolytic pathway and the citric acid cycle.
17
18. Elderly and demented at increased susceptibility of older adults to
dehydration and the resulting complications, including delirium
Dehydration can lead to
• hypoperfusion (both cerebral and renal)
• increased concentration of drugs and/or their metabolites,
• extravascular changes, leading to water and electrolyte
imbalances,
18
20. Elevations of DA have long been associated with the development
of delirium.
Impaired oxidative conditions lead to significant increases in DA
because
e influx of Ca++ also stimulates DA release,.
Ca++ influx stimulates tyrosine hydroxylase which converts DOPA to DA ➙
increased DA production.
e breakdown in ATP-dependent transporters ➙ decrease in DA reuptake.
Decreased ATP ➙ decreased COMT activity ➙ decreased DA degradation.
DA agonists can create slower EEG in spite of motor hyperactivity,
which represents a perfect symptomatological match to hyperactive
delirium.
20
21. It has long been recognized that acute stress and non-CNS illness frequently affect
attention, cognition, motivation, mood, and perception
severity of the patient’s initial injury or underlying medical problem as measured by
APACHE scores is significantly directly correlated with the development of delirium
One of the characteristic features of POD is the LUCID INTERVAL, namely time
delay between the triggering insult (operation) and POD development
they mostly appear on the second or third postoperative day.
Explanation is offered by the common course of inflammatory cascade: while its
development begins quickly after stimulation, terminal effectors reach the peak
activity after 24 h or later. Increasing extravascular edema formation and
intravascular leukocyte adhesion further impair nutritive function of brain
capillaries.
Inflammation helps explain why dementia is such an important risk factor
21
22. Normally the BBB blocks most cytokines which disrupt neuronal function, but
chronic neurodegeneration seen in dementia primes microglia to respond more
vigorously to increased levels of the pro-inflammatory cytokine induced by systemic
insults
systemic inflammation as a response to surgical trauma may cause diffuse
microcirculatory impairment via leukocyte adhesion and endothelial activation
Perivascular edema causes longer diffusion distance for oxygen to reach the nerve
cells leading to hypoxia and all its consequences just mentioned.
22
23. Hypercortisolism has adverse effects on mood, sleep, energy, and cognition,
especially in elderly persons and is known to cause delirium in association with
surgery, Cushing’s syndrome, and dementia.
In demented patients, cortisol concentrations as measured by DST correlates with
the severity of the delirium
Excessive glucocorticoid levels seem to induce a vulnerable state in neurons.
Glucocorticoid excess has numerous adverse effects including
• inhibition of calcium efflux or sequestration,
• and cause energy failure of neurons by inhibiting glucose transport into cells
e hippocampus is a major target for these effects with its dense concentration of
GR.
e hippocampal formation is of prime importance for normal HPA axis shut-off.
is disruption of normal hippocampal activity will further disinhibit the release of
cortisol, thus sustaining high levels of circulating cortisol
23
24. It is well know the delirium causes disruptions in the circadian rhythms, but it is
little appreciated how iatrogenic disruptions in the circadian rhythms cause delirium.
chronic partial sleep deprivation’’ (i.e., sleeping limited to 4 hours per night, for 5
consecutive nights) translates into cumulative impairment in attention, critical
thinking, reaction time, recall, and emotional imbalance (i.e., short temper, mood
swings, and excessive emotional response)
the average ICU patient sleeps just under 2 hours in 24-hour period
24
26. GABAergic medications have been shown to be some of the most significant and frequent
culprits to cause delirium
the use of benzodiazepines has been identified as an independent risk factor for the development
of delirium as shown in this graph
ere are several mechanisms by which sedative agents (e.g., benzodiazepines, propofol)
contribute to delirium:
(1) interfere with physiologic sleep patterns
(2) cause a centrally mediated acetylcholine deficient state
(3) disruption of thalamic gating function leading to sensory overload and hyper-arousal.
26
27. Homeostenosis of aging
Inflammatory priming of dementia
Stress induced neuronal vulnerability of critical illness
Human and pharmacologic disturbance of natural rhythms and balances
Lead to
Arousal, attention, and memory impairment because decreased cholinergic function.
&
Agitation, aggression, and psychosis because increased dopaminergic activity.
Any one of these could be the main etiology in any given case of delirium and that is
why it is critical to know how they all interact to prevent and manage delirium
27
28. I have only been on the floors a few months now, and already I’ve seen this scenario
countless times:
A critically ill patient is agitated, so the intern, resident or attending just throws some
benzos or opioids at the problem and follow up later.
it should be clear from the pathophysiology that not only is the patient likely
delirious but that both options are exactly the wrong choice not only in that they
will potentially exacerbate the patient’s delirium but my also tip a marginally hypoxic
patient to a critically hypoxic one.
28
29. Because delirium is so multifactorial prevention is essentially just good patient care.
at said, I’d like to highlight
1. Avoid/discontinue inappropriate or unnecessary medications.
2. judicious analgesic prescription.
3. avoid the routine use of sedatives.
4. Promote physiologic rhythms in sleep, bowel and bladder function,
5. Avoid dehydration and even minor hypoxia
6. Provide reorientation and sensory aids (e.g., eyeglasses, hearing aids)
29
30. Knowing the major offenders is half the battle and so I’ve highlighted them here
30
33. Non pharmacologic treatment is the same as prevention but with
•Monitor the older person’s physiological condition/mental status.
•Evaluate response to care provided and modify as indicated.
33
34. 1. e use of psychotropic medications to treat the symptoms of delirium
should be reserved:
a) for patients in significant distress due to agitation or psychotic
symptoms;
b) in order to carry out essential investigations or treatment; and/or
c) to prevent older delirious persons from endangering themselves or
others.
2. When using psychotropic medications aim for monotherapy, the lowest
effective dose and tapering as soon as possible.
3. Antipsychotics are the treatment of choice. Haloperidol, when used
appropriately, is a reasonable choice for most patients.
4. Atypical antipsychotics are alternative agents to haloperidol, and are preferred
for patients who also have Parkinson’s Disease or Lewy Body Dementia.
5. Baseline and follow up ECG recommended with antipsychotics. For
prolongation of QTc intervals to >450 msec or a >25% increase over baseline,
consider cardiology consultation and antipsychotic discontinuation.
6. Benzodiazepines can exacerbate delirium. eir use should be reserved for
older persons with delirium caused by withdrawal from alcohol/sedative-
hypnotics.
34